About
AirBiometrics develops affordable technological solutions to facilitate the diagnosis and monitoring of chronic inflammatory diseases such as Crohn's disease and ulcerative colitis by analyzing patient data to support personalized treatment plans.
Explore AirBiometrics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.